Orexigen Therapeutics Inc (NASDAQ:OREX)

5.70
Data as of Aug 29
 -0.03 / -0.52%
Today’s Change
4.60
Today|||52-Week Range
7.82
+1.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 4
2013
Quarter 1
2014
Quarter 3
2014
Revenue and IncomeNet Revenues857.0K857.0K857.0K857.0K
 
 
 
 
 
Depreciation And Amortization5.0K10.0K8.0K38.0K
 
 
 
 
 
 
Operating ExpensesGross Income----849.0K--
 
 
General Expenses19.4M21.8M24.0M23.6M
 
 
 
 
 
Research And Development13.0M15.5M17.0M16.7M
 
 
 
 
 
Total Operating Expenses19.4M21.8M24.0M23.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.6M-21.0M-23.2M-22.8M
 
 
 
 
 
Interest Expense On Debt0.00537.0K1.8M1.7M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.6M-21.5M-24.9M-24.5M
 
 
 
 
 
Net Income-18.6M-21.5M-24.9M-24.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS98.7M101.8M109.2M118.0M
 
 
 
 
 
Shares To Calculate EPS Diluted98.7M101.8M109.2M118.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.21-$0.23-$0.21
 
 
 
 
 
EPS Diluted-$0.19-$0.21-$0.23-$0.21
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.